drugset / Trial / NCT05318833
A Study of HRS7415 Tablets in Patients With Advanced Malignant Tumors
NaSingle-groupOpen-labelTreatment
Summary
This study is a multicenter, open phase I clinical study of dose escalation and dose extension of HRS7415 in subjects with advanced malignant tumors. To evaluate the safety, tolerability, pharmacokinetics and efficacy of HRS7415 tablets.
Timeline
- Start
- 2022-05-12
- Primary completion
- 2025-03-20
- Completion
- 2025-03-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS7415 | Unknown | — | — |